Web-Based Online Clinical Drug Information Solution

Question deadline: March 25th, 2026

Response deadline: April 1st, 2026

Base period begins: July 15th, 2026

Final option period ends: July 14th, 2031

The agency is seeking a vendor to provide a web-based, online clinical drug information solution that offers continuous access to an evidence-based, comprehensive drug reference resource. The solution must deliver a commercial online pharmaceutical reference database accessible 24/7 to authorized agency users, with compatibility across both networked and non-networked devices, including desktops, laptops, and mobile devices (iOS and Android).

The contractor will be responsible for furnishing all aspects required for effective use, including subscription access, regular updates, user support, training, and detailed reporting. The platform must feature a unified search interface capable of simultaneously querying medication, toxicology, disease management, and patient education databases, equipped with advanced search functionality.

Key requirements include transparent evidence and recommendation rating systems, comprehensive medication monographs with detailed dosing, administration, contraindications, precautionary information, and adverse effect data stated with frequency percentages. The system must also cover off-label drug use information, a drug interaction database, and drug consult modules providing guidelines, comparative tables, chemotherapy regimens, and clinical summaries. In addition, the solution must present black box warnings with FDA links, off-label use summaries, pregnancy/lactation data, and hazardous drug screening resources in compliance with recognized standards. The initial contract period will be for one year.